Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Selling General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Clinical trial expenses | 23,102 | 33,511 | 41,406 | 66,658 |
| Facility- and technology-related expenses (excluding depreciation and amortization) | 23,890 | 28,580 | 46,832 | 56,237 |
| Research and development- other (excluding non-cash items) (1) | 19,847 | 31,843 | 38,518 | 60,314 |
| Selling, general and administrative- other (excluding non-cash items) (2) | 42,462 | 56,322 | 82,655 | 107,464 |
| Roche collaboration reimbursement | (7,169) | (25,689) | (15,358) | (54,170) |
| Other segment items (3) | (709) | (1,314) | (2,515) | (3,223) |
| Loss (gain) on strategic investments | 448 | (36,721) | 2,160 | 54,007 |
| Interest expense | 21,508 | 5,228 | 43,221 | 9,731 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — selling general and administrative expense of $42.46M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense decreased by 24.6% year-over-year, from $56.32M to $42.46M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense has grown at a 18.4% compound annual growth rate (CAGR), from $124.95M to $207.19M.
- What does business segments — selling general and administrative expense mean?
- Represents the operating expenses incurred for the administration, marketing, and sales support of the segment. It is a key metric for evaluating the segment's operational overhead and commercialization efficiency.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — selling general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude